Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113051-113100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02702310
Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
N/A
Recruiting
60 participants
Started: May 22, 2016 · Completed: Sep 30, 2026
5 conditions
2 sponsors
1 location
NCT02628405
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: May 20, 2016 · Completed: Dec 20, 2025
8 conditions
2 sponsors
12 locations
NCT02676739
Adderall XR and Cognitive Impairment in MS
PHASE2/PHASE3
Active, not recruiting
180 participants
Started: May 20, 2016 · Completed: Dec 31, 2024
1 condition
1 sponsor
3 locations
NCT02750358
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
PHASE2
Active, not recruiting
50 participants
Started: May 19, 2016 · Completed: May 31, 2026
3 conditions
3 sponsors
12 locations
NCT02339922
Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
PHASE2
Active, not recruiting
33 participants
Started: May 19, 2016 · Completed: Jan 6, 2031
9 conditions
2 sponsors
1 location
NCT02568566
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
PHASE2
Active, not recruiting
201 participants
Started: May 19, 2016 · Completed: Jan 10, 2026
1 condition
1 sponsor
2 locations
NCT02711553
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
PHASE2
Active, not recruiting
309 participants
Started: May 19, 2016 · Completed: Dec 31, 2026
3 conditions
1 sponsor
82 locations
NCT02727803
Personalized NK Cell Therapy in CBT
PHASE2
Recruiting
100 participants
Started: May 19, 2016 · Completed: May 31, 2027
26 conditions
2 sponsors
1 location
NCT02780310
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
PHASE2
Active, not recruiting
33 participants
Started: May 19, 2016 · Completed: May 31, 2026
1 condition
2 sponsors
6 locations
NCT02617849
Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
PHASE2
Active, not recruiting
30 participants
Started: May 19, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT02734134
One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection
NA
Active, not recruiting
343 participants
Started: May 18, 2016 · Completed: Jan 31, 2026
1 condition
14 sponsors
5 locations
NCT02682641
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
PHASE2
Active, not recruiting
50 participants
Started: May 18, 2016 · Completed: Dec 31, 2024
1 condition
2 sponsors
15 locations
NCT02703623
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2
Active, not recruiting
196 participants
Started: May 18, 2016 · Completed: Mar 31, 2026
5 conditions
2 sponsors
3 locations
NCT03293758
Food and Microbiome Longitudinal Investigation (FAMiLI)
N/A
Recruiting
14,000 participants
Started: May 16, 2016 · Completed: Dec 31, 2034
2 conditions
2 sponsors
1 location
NCT02758717
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
PHASE2
Active, not recruiting
46 participants
Started: May 13, 2016 · Completed: Sep 13, 2025
11 conditions
2 sponsors
9 locations
NCT02609685
Active Surveillance of Papillary Thyroid Microcarcinoma
NA
Recruiting
216 participants
Started: May 13, 2016 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT03578484
Breast Aesthetics by Three Dimensional Measures
N/A
Active, not recruiting
32 participants
Started: May 13, 2016 · Completed: Mar 20, 2032
1 condition
8 sponsors
2 locations
NCT02496663
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
PHASE1
Active, not recruiting
138 participants
Started: May 11, 2016 · Completed: Jun 30, 2027
3 conditions
1 sponsor
15 locations
NCT02668770
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
PHASE1
Active, not recruiting
28 participants
Started: May 11, 2016 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT02706639
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank
N/A
Recruiting
1,099 participants
Started: May 11, 2016 · Completed: Sep 25, 2040
3 conditions
1 sponsor
3 locations
NCT03650010
Total Ankle Replacement: Clinical and Radiological Outcomes
N/A
Recruiting
1,066 participants
Started: May 11, 2016 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT02600949
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
PHASE1
Enrolling by invitation
150 participants
Started: May 11, 2016 · Completed: May 31, 2027
6 conditions
2 sponsors
1 location
NCT03271892
Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer
N/A
Active, not recruiting
200 participants
Started: May 11, 2016 · Completed: Dec 31, 2031
1 condition
4 sponsors
1 location
NCT02772367
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
N/A
Recruiting
120 participants
Started: May 11, 2016 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT03042221
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
N/A
Recruiting
100 participants
Started: May 10, 2016 · Completed: Sep 30, 2027
6 conditions
1 sponsor
1 location
NCT02986568
Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers
NA
Recruiting
380 participants
Started: May 10, 2016 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT02466971
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
PHASE3
Active, not recruiting
450 participants
Started: May 10, 2016 · Completed: Jul 14, 2026
21 conditions
2 sponsors
382 locations
NCT02781870
Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible Mesh With or Without LiquiBand Fix 8 Mesh Fixation
NA
Recruiting
100 participants
Started: May 9, 2016 · Completed: Aug 31, 2027
2 conditions
2 sponsors
1 location
NCT02729974
Use of ROTEM Intraoperatively in Women With Placenta Accreta
NA
Enrolling by invitation
40 participants
Started: May 8, 2016 · Completed: Dec 31, 2024
1 condition
1 sponsor
0 locations
NCT02398773
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
PHASE2
Active, not recruiting
99 participants
Started: May 4, 2016 · Completed: Dec 31, 2025
4 conditions
1 sponsor
25 locations
NCT02726386
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
PHASE2
Active, not recruiting
214 participants
Started: May 4, 2016 · Completed: Feb 28, 2027
1 condition
1 sponsor
57 locations
NCT03399929
Traumatic Brain Injury and Stroke Long Term Outcome
N/A
Recruiting
240 participants
Started: May 4, 2016 · Completed: May 4, 2028
2 conditions
1 sponsor
1 location
NCT04352569
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia
NA
Recruiting
44 participants
Started: May 3, 2016 · Completed: Mar 10, 2026
3 conditions
1 sponsor
1 location
NCT02502266
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
PHASE2/PHASE3
Active, not recruiting
582 participants
Started: May 3, 2016 · Completed: Jul 16, 2026
15 conditions
3 sponsors
398 locations
NCT02650401
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
PHASE1/PHASE2
Active, not recruiting
69 participants
Started: May 3, 2016 · Completed: Jun 30, 2026
2 conditions
1 sponsor
27 locations
NCT02452008
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
PHASE2
Active, not recruiting
60 participants
Started: May 3, 2016 · Completed: May 31, 2026
1 condition
3 sponsors
4 locations
NCT02354014
Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB
PHASE2
Recruiting
60 participants
Started: May 3, 2016 · Completed: Feb 11, 2027
1 condition
1 sponsor
11 locations
NCT02970045
Norris ORIEN Total Cancer Care
N/A
Recruiting
10,000 participants
Started: May 2, 2016 · Completed: May 2, 2037
2 conditions
2 sponsors
1 location
NCT02708134
Quality of Pediatric Resuscitation in a Multicenter Collaborative
N/A
Recruiting
7,000 participants
Started: May 2, 2016 · Completed: Jan 31, 2030
2 conditions
2 sponsors
61 locations
NCT03088098
Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI
NA
Active, not recruiting
80 participants
Started: May 2, 2016 · Completed: Sep 14, 2024
2 conditions
2 sponsors
1 location
NCT02760849
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
NA
Active, not recruiting
374 participants
Started: May 2, 2016 · Completed: May 31, 2041
14 conditions
2 sponsors
9 locations
NCT05664282
Orthodontic Treatment in Adolescents With Crowding and Displaced Teeth
NA
Active, not recruiting
131 participants
Started: May 1, 2016 · Completed: Dec 31, 2027
2 conditions
1 sponsor
0 locations
NCT02681328
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
N/A
Active, not recruiting
328 participants
Started: May 1, 2016 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03113513
Comparison of Two Apical Repair Methods in Women Undergoing Repairs for Prolapse
NA
Active, not recruiting
312 participants
Started: May 1, 2016 · Completed: Apr 30, 2025
4 conditions
1 sponsor
1 location
NCT03535155
Ultrasound Identification Automation Study
N/A
Active, not recruiting
100 participants
Started: May 1, 2016 · Completed: Dec 31, 2026
1 condition
2 sponsors
0 locations
NCT03077269
Understanding Coagulation and Inflammation in Burns
N/A
Active, not recruiting
250 participants
Started: May 1, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04613583
Scottish Advanced Fetal Research Study
N/A
Recruiting
1,200 participants
Started: May 1, 2016 · Completed: Oct 1, 2025
4 conditions
2 sponsors
1 location
NCT06599047
Regional Adipose Tissue Characteristics in Type II Diabetes
N/A
Recruiting
140 participants
Started: May 1, 2016 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location
NCT02939664
Laparoscopic Gastric Bypass Versus Laparoscopic Banded Gastric Bypass Randomized Prospective Clinical Trial
NA
Enrolling by invitation
80 participants
Started: Apr 30, 2016 · Completed: Jan 31, 2034
3 conditions
1 sponsor
1 location
NCT02754037
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
N/A
Active, not recruiting
120 participants
Started: Apr 30, 2016 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
Previous
1
More pages
2259
2260
2261
2262
2263
2264
2265
More pages
2369
Next